Rheumatology
1151 – 1160 of 1580
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
BAL fluid derived fibroblasts differ from biopsy derived fibroblasts in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein and factor h compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack
(
- Contribution to journal › Article
-
Mark
Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
(
- Contribution to journal › Article
-
Mark
Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
(
- Contribution to journal › Article
-
Mark
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity
(
- Contribution to journal › Article
-
Mark
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
(
- Contribution to journal › Article
-
Mark
Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
No evidence of association between genetic variants of the PDCD1 ligands and SLE
(
- Contribution to journal › Article
-
Mark
Treatment of pulmonary fibrosis in systemic sclerosis: Light at the end of the tunnel?
(
- Contribution to journal › Letter